Perceptions About the Acceptability of Assessments of HIV Medication Adherence in Lilongwe, Malawi and Chennai, India

Little research exists on acceptability issues related to assessments of adherence to ART in resource-poor settings. To help prepare for two large-scale, multisite ART intervention trials, this qualitative study of individuals in Chennai, India (49 men, 11 women; 33 taking ART, 27 not) and Lilongwe, Malawi (5 men, 5 women, all taking ART) examined potential limitations of different types of adherence assessments: an adherence questionnaire, a pill diary, a pillbox, an electronic pill cap, and a medication punch card. Many participants reported that the various assessments would be acceptable. Potential limitations included issues surrounding literacy, the desire to appease one’s medical provider, privacy and stigma, and “cheating.” These potential limitations are similar to the limitations of these assessments in Western settings. However, the data highlight the need to consider individual patient level concerns when assessing ART adherence in different cultural settings. Innovative ways of monitoring adherence while maintaining standardization across sites are required in multisite trials.

[1]  M. Chesney,et al.  Adherence to HIV combination therapy. , 2000, Social science & medicine.

[2]  A. Wu,et al.  Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments , 2000, AIDS care.

[3]  D. Bangsberg,et al.  Measuring Adherence to Antiretroviral Therapy in a Diverse Population Using a Visual Analogue Scale , 2004, HIV clinical trials.

[4]  R. Grant,et al.  Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  Susan Swindells,et al.  Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection , 2000, Annals of Internal Medicine.

[6]  P. Rudd,et al.  Improved compliance measures: Applications in an ambulatory hypertensive drug trial , 1990, Clinical pharmacology and therapeutics.

[7]  M. Otto,et al.  Two strategies to increase adherence to HIV antiretroviral medication: life-steps and medication monitoring. , 2001, Behaviour research and therapy.

[8]  K. Calzone,et al.  Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  D. Bangsberg,et al.  Multiple Validated Measures of Adherence Indicate High Levels of Adherence to Generic HIV Antiretroviral Therapy in a Resource-Limited Setting , 2004, Journal of acquired immune deficiency syndromes.

[10]  The 3 by 5 initiative. , 2004, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[11]  K. Mayer,et al.  ART adherence, demographic variables and CD4 outcome among HIV-positive patients on antiretroviral therapy in Chennai, India , 2005, AIDS care.

[12]  J. Rabkin,et al.  Adherence: a necessity for successful HIV combination therapy. , 1999, AIDS.

[13]  H. Roth,et al.  Accuracy of doctors' estimates and patients' statements on adherence to a drug regimen , 1978, Clinical pharmacology and therapeutics.

[14]  J. Cramer,et al.  How often is medication taken as prescribed? A novel assessment technique. , 1989, JAMA.

[15]  R. Haynes,et al.  Is this patient taking the treatment as prescribed , 1993 .

[16]  A Nicoll,et al.  Selective versus universal antenatal HIV testing: epidemiological and implementational factors in policy choice. , 1999, AIDS.

[17]  S. Boswell,et al.  Use of an on-line pager system to increase adherence to antiretroviral medications , 2003, AIDS care.

[18]  W. Carter,et al.  Screening for noncompliance among patients with hypertension: is self-report the best available measure? , 1981, Medical care.

[19]  F. Hecht,et al.  Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population , 2000, AIDS.

[20]  K. Mayer,et al.  Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: a qualitative study. , 2005, AIDS patient care and STDs.